Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs Klinic

HealthRX
Graded #5

Higher grade

vs+25.3
Klinic
Graded #349

Lower grade

The verdict

HealthRX takes it — 86.1/100 to 60.8/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +40
85
45
Dose & formulationHealthRX +37
90
53
Clinical oversightHealthRX +8
87
79
Labs & monitoringHealthRX +18
82
64
FulfillmentHealthRX +10
86
76
Contract termsHealthRX +30
85
55
HealthRX · left barKlinic · right bar

The numbers

MetricHealthRXKlinic
WeighScore86.1/10060.8/100
GradeBC
Scorecard rank#5#349
Semaglutide$190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188)Varies (branded medication; visits extra)
Tirzepatide$239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148)Varies (branded medication; visits extra)
CoverageNot publicly listedNationwide; confirm provider availability
Brand-name accessYesYes
Oral / sublingualYesYes
HealthRX

Graded #5 · B

Strengths

  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
Klinic

Graded #349 · C

Strengths

  • Offers provider matching, insurance verification and prior-authorization support
  • Wegovy, Zepbound and oral Wegovy treatment pages are published
  • Zepbound program describes assistance with insurance appeals
  • Publishes self-pay visit fees: from $99 initially and $75 for follow-ups

Where it loses points

  • Medication is extra; there is no single published total covering visits and every prescription
  • Insurance acceptance and benefit verification do not guarantee payment
  • Terms describe monthly membership renewal and cancellation notice 14 business days before billing; confirm applicability to your plan
  • Care is delivered by independent practitioners; confirm the provider and dispensing pharmacy before starting

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard